Aspen has the rights to manufacture and market the S-26 and SMA brands in southern Africa, Australia and Latin America. This, combined with the strong position of the Infacare brand in Africa, gives Aspen a strong infant nutritionals presence on four continents and positions it as the 15th largest infant nutritionals business globally with an estimated 0,70% of worldwide market share (source: Euromonitor). In addition, Aspen is one of only two companies in the top 15 that is also a pharmaceutical company, providing additional credibility due to Aspen’s rigorous safety and quality standards.
Short-term palliative treatment of acute episodes or exacerbations and systemic complications of rheumatic disorders (., rheumatoid arthritis, juvenile arthritis, psoriatic arthritis, acute gouty arthritis, posttraumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis, acute nonspecific tenosynovitis, ankylosing spondylitis, Reiter syndrome † , rheumatic fever † [especially with carditis]) and collagen diseases (., acute rheumatic carditis, systemic lupus erythematosus, dematomyositis † [polymyositis], polyarteritis nodosa † , vasculitis † ) refractory to more conservative measures. a c d f
Acne is often present. Acne conglobata is a particularly severe form of acne that can develop during steroid abuse or even after the drug has been discontinued. Infections are a common side effect of steroid abuse because of needle sharing and unsanitary techniques used when injecting the drugs into the skin. These are similar risks to IV drug abusers with increased potential to acquire blood-borne infections such as hepatitis and HIV/AIDS . Skin abscesses may occur at injection sites and may spread to other organs of the body. Endocarditis or an infection of the heart valves is not uncommon.